PharmaRoth Labs (PharmaRoth Labs) Long-Term Debt : $0.00 Mil (As of Mar. 2011)

View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs Long-Term Debt?

PharmaRoth Labs's Long-Term Debt for the quarter that ended in Mar. 2011 was $0.00 Mil.

PharmaRoth Labs's annual Long-Term Debt stayed the same from Jun. 2008 ($0.00 Mil) to Jun. 2009 ($0.00 Mil) but then increased from Jun. 2009 ($0.00 Mil) to Jun. 2010 ($0.25 Mil).

PharmaRoth Labs Long-Term Debt Historical Data

The historical data trend for PharmaRoth Labs's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs Long-Term Debt Chart

PharmaRoth Labs Annual Data

Trend

Jun08

Jun09

Jun10

Long-Term Debt

0.25

PharmaRoth Labs Quarterly Data
	Mar07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Long-Term Debt	Get a 7-Day Free Trial											-	0.25	-	-	-

PharmaRoth Labs (GREY:ROTH) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

PharmaRoth Labs Long-Term Debt Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaRoth Labs (PharmaRoth Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117

Website

http://www.pharmaroth.com

PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines

From GuruFocus

Hotchkis and Wiley Value Opportunities Fund Buys Rothschild SCA, Oracle Corp, Medtronic PLC, Sells Amerco Inc, Anthem Inc, F5 Inc

By GuruFocusNews insider • 03-29-2022